SE384208B - Sett att framstella nya 2,6-diamino-dihydropyridiner - Google Patents

Sett att framstella nya 2,6-diamino-dihydropyridiner

Info

Publication number
SE384208B
SE384208B SE7303021A SE7303021A SE384208B SE 384208 B SE384208 B SE 384208B SE 7303021 A SE7303021 A SE 7303021A SE 7303021 A SE7303021 A SE 7303021A SE 384208 B SE384208 B SE 384208B
Authority
SE
Sweden
Prior art keywords
dihydropyridines
diamino
way
make new
new
Prior art date
Application number
SE7303021A
Other languages
English (en)
Swedish (sv)
Inventor
H Meyer
F Bossert
W Vater
K Stoepel
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of SE384208B publication Critical patent/SE384208B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Vascular Medicine (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
SE7303021A 1972-03-06 1973-03-05 Sett att framstella nya 2,6-diamino-dihydropyridiner SE384208B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2210687A DE2210687C3 (de) 1972-03-06 1972-03-06 2,6-Diamino-3,5-diäthoxycarbonyldihydropyridine, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
SE384208B true SE384208B (sv) 1976-04-26

Family

ID=5838037

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7303021A SE384208B (sv) 1972-03-06 1973-03-05 Sett att framstella nya 2,6-diamino-dihydropyridiner

Country Status (24)

Country Link
JP (2) JPS5626659B2 (ja)
KR (1) KR780000119B1 (ja)
AT (3) ATA925774A (ja)
BE (1) BE796279A (ja)
BG (2) BG22815A3 (ja)
CA (1) CA988524A (ja)
CH (2) CH577473A5 (ja)
CS (2) CS182781B2 (ja)
DD (1) DD106833A5 (ja)
DE (1) DE2210687C3 (ja)
DK (1) DK136061C (ja)
ES (1) ES412323A1 (ja)
FI (1) FI55996C (ja)
FR (1) FR2181789B1 (ja)
GB (1) GB1379005A (ja)
HU (1) HU167089B (ja)
IE (1) IE37370B1 (ja)
IL (1) IL41664A (ja)
LU (1) LU67147A1 (ja)
NL (1) NL7303137A (ja)
PL (2) PL92078B1 (ja)
RO (2) RO63068A (ja)
SE (1) SE384208B (ja)
ZA (1) ZA731501B (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2210687C3 (de) * 1972-03-06 1981-09-24 Bayer Ag, 5090 Leverkusen 2,6-Diamino-3,5-diäthoxycarbonyldihydropyridine, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
DE2406198C2 (de) * 1974-02-09 1983-12-15 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von neuen 2-Amino-6-dialkylamino-dihydropyridinen
JPS5922594U (ja) * 1982-08-03 1984-02-10 日本マランツ株式会社 耳栓型ヘツドホ−ン
JPS5922593U (ja) * 1982-08-03 1984-02-10 日本マランツ株式会社 ヘツドホ−ン用ホ−ン部取付構造
JPS6282898A (ja) * 1985-10-08 1987-04-16 Matsushita Electric Ind Co Ltd ヘツドホン
JPS6293060U (ja) * 1985-11-28 1987-06-13

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2210687C3 (de) * 1972-03-06 1981-09-24 Bayer Ag, 5090 Leverkusen 2,6-Diamino-3,5-diäthoxycarbonyldihydropyridine, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
US3855231A (en) * 1972-03-06 1974-12-17 Bayer Ag 2,6-diamino-1,4-dihydropyridine derivatives
DE2406198C2 (de) * 1974-02-09 1983-12-15 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von neuen 2-Amino-6-dialkylamino-dihydropyridinen

Also Published As

Publication number Publication date
CH580589A5 (ja) 1976-10-15
ZA731501B (en) 1973-11-28
CA988524A (en) 1976-05-04
KR780000119B1 (en) 1978-04-15
ES412323A1 (es) 1976-01-01
DE2210687A1 (de) 1973-09-20
FI55996B (fi) 1979-07-31
DE2210687B2 (de) 1980-09-04
IE37370B1 (en) 1977-07-06
BG22815A3 (bg) 1977-04-20
FR2181789B1 (ja) 1976-12-03
JPS48103579A (ja) 1973-12-25
CH577473A5 (ja) 1976-07-15
RO61192A (ja) 1976-09-15
IL41664A (en) 1976-01-30
NL7303137A (ja) 1973-09-10
JPS5911584B2 (ja) 1984-03-16
HU167089B (ja) 1975-08-28
LU67147A1 (ja) 1973-05-22
DK136061C (da) 1978-01-02
RO63068A (ja) 1978-05-15
CS182781B2 (en) 1978-05-31
AT324338B (de) 1975-08-25
BE796279A (fr) 1973-09-05
FR2181789A1 (ja) 1973-12-07
AT327904B (de) 1976-02-25
BG20583A3 (bg) 1975-12-05
GB1379005A (en) 1975-01-02
DD106833A5 (ja) 1974-07-05
IL41664A0 (en) 1973-05-31
DE2210687C3 (de) 1981-09-24
JPS5626659B2 (ja) 1981-06-19
ATA925774A (de) 1975-05-15
DK136061B (da) 1977-08-08
FI55996C (fi) 1979-11-12
IE37370L (en) 1973-09-06
PL92078B1 (ja) 1977-03-31
PL89256B1 (ja) 1976-11-30
JPS5699460A (en) 1981-08-10
CS182792B2 (en) 1978-05-31

Similar Documents

Publication Publication Date Title
SE7614680L (sv) Sett att framstella nya bensodiazepinderivat
SE421615B (sv) Sett att framstella nya tiazolderivat
SE403777B (sv) Sett att framstella nya 1,4-dihydropyridin-polyestrar
SE411349B (sv) Sett att framstella nya penicilliner
SE7711848L (sv) Sett att framstella nya 5-metyl-7-hydroxi-isoflavonderivat
SE410600B (sv) Sett att framstella nya arylaminopyrimidinderivat
SE400295B (sv) Sett att framstella nya 2,6-diaminonebularinderivat
ES205732Y (es) Juguete.
SE386164B (sv) Sett att framstella nya 2-alkylamino-dihydropyridiner
SE417211B (sv) Sett att framstella indenyl-3-acetoglucuronider
SE405966B (sv) Sett att framstella peptider
BE802531A (fr) D-6-methyl-ergolines 2,8-disubstitutuees
SE384208B (sv) Sett att framstella nya 2,6-diamino-dihydropyridiner
SE7411948L (sv) Nya d-homosteroider.
SE385882B (sv) Sett att framstella nya 3,4-dihydropyridoner
SE413022B (sv) Sett att framstella nya propylendiaminderivat
SE7610170L (sv) Sett att framstella nya aminoimidazol-isokinolinderivat
SE396608B (sv) Sett att framstella nya penicilliner
SE403285B (sv) Sett att framstella nya 1,4-dihydrokinoliner
SE395007B (sv) Sett att framstella 9,10-seko-ostranderivat
SE7702331L (sv) Sett att framstella vinkamon
NL7410301A (nl) Gesubstitueerde fenylglycylcefalosporinen.
SE408298B (sv) Sett att framstella nya substituerade diamino-bensofenoner
SE419648B (sv) Sett att framstella nya anhydrofuranosderivat
SE385709B (sv) Sett att framstella nya steroid-4,9,11-triengonaner